Annual Total Liabilities
$29.65 M
-$13.77 M-31.71%
01 July 2024
Summary:
Enzo Biochem annual total liabilities is currently $29.65 million, with the most recent change of -$13.77 million (-31.71%) on 01 July 2024. During the last 3 years, it has fallen by -$15.45 million (-34.26%). ENZ annual total liabilities is now -50.16% below its all-time high of $59.50 million, reached on 31 July 1989.ENZ Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$29.65 M
+$5.21 M+21.34%
01 July 2024
Summary:
Enzo Biochem quarterly total liabilities is currently $29.65 million, with the most recent change of +$5.21 million (+21.34%) on 01 July 2024. Over the past year, it has dropped by -$2.38 million (-7.43%). ENZ quarterly total liabilities is now -50.16% below its all-time high of $59.50 million, reached on 31 July 1989.ENZ Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | -7.4% |
| 3 y3 years | -34.3% | -28.3% |
| 5 y5 years | +43.9% | -36.8% |
ENZ Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -34.3% | +40.2% | -44.2% | +40.2% |
| 5 y | 5 years | -45.3% | +43.9% | -45.6% | +40.2% |
| alltime | all time | -50.2% | +3606.5% | -50.2% | +3606.5% |
Enzo Biochem Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $29.65 M(-31.7%) | $29.65 M(+21.3%) |
| Apr 2024 | - | $24.44 M(-13.7%) |
| Jan 2024 | - | $28.30 M(-11.6%) |
| Oct 2023 | - | $32.03 M(-26.2%) |
| July 2023 | $43.42 M(+105.3%) | $43.42 M(-18.3%) |
| Apr 2023 | - | $53.13 M(+21.8%) |
| Jan 2023 | - | $43.62 M(+8.5%) |
| Oct 2022 | - | $40.21 M(+90.1%) |
| July 2022 | $21.15 M(-53.1%) | $21.15 M(-49.3%) |
| Apr 2022 | - | $41.72 M(-4.5%) |
| Jan 2022 | - | $43.70 M(+5.6%) |
| Oct 2021 | - | $41.38 M(-8.3%) |
| July 2021 | $45.10 M(-16.7%) | $45.10 M(-7.3%) |
| Apr 2021 | - | $48.66 M(-3.2%) |
| Jan 2021 | - | $50.24 M(-7.8%) |
| Oct 2020 | - | $54.48 M(+0.6%) |
| July 2020 | $54.16 M(+162.7%) | $54.16 M(+0.3%) |
| Apr 2020 | - | $54.02 M(+17.6%) |
| Jan 2020 | - | $45.92 M(-2.1%) |
| Oct 2019 | - | $46.91 M(+127.6%) |
| July 2019 | $20.61 M(+0.4%) | $20.61 M(+3.1%) |
| Apr 2019 | - | $20.00 M(-7.5%) |
| Jan 2019 | - | $21.62 M(+16.8%) |
| Oct 2018 | - | $18.51 M(-9.9%) |
| July 2018 | $20.54 M(+9.3%) | $20.54 M(+7.7%) |
| Apr 2018 | - | $19.07 M(-6.4%) |
| Jan 2018 | - | $20.37 M(+1.5%) |
| Oct 2017 | - | $20.07 M(+6.8%) |
| July 2017 | $18.79 M(-15.6%) | $18.79 M(+4.3%) |
| Apr 2017 | - | $18.02 M(-3.5%) |
| Jan 2017 | - | $18.66 M(-15.1%) |
| Oct 2016 | - | $21.98 M(-1.3%) |
| July 2016 | $22.27 M(-13.7%) | $22.27 M(-5.3%) |
| Apr 2016 | - | $23.52 M(-11.1%) |
| Jan 2016 | - | $26.46 M(-2.7%) |
| Oct 2015 | - | $27.18 M(+5.4%) |
| July 2015 | $25.79 M(-6.1%) | $25.79 M(+5.4%) |
| Apr 2015 | - | $24.46 M(-0.9%) |
| Jan 2015 | - | $24.68 M(-6.9%) |
| Oct 2014 | - | $26.51 M(-3.5%) |
| July 2014 | $27.46 M(+10.6%) | $27.46 M(+11.7%) |
| Apr 2014 | - | $24.59 M(+4.5%) |
| Jan 2014 | - | $23.54 M(-6.5%) |
| Oct 2013 | - | $25.19 M(+1.5%) |
| July 2013 | $24.83 M(+24.0%) | $24.83 M(+11.8%) |
| Apr 2013 | - | $22.21 M(+1.2%) |
| Jan 2013 | - | $21.94 M(+3.0%) |
| Oct 2012 | - | $21.29 M(+6.3%) |
| July 2012 | $20.02 M(-3.6%) | $20.02 M(+4.8%) |
| Apr 2012 | - | $19.11 M(-4.0%) |
| Jan 2012 | - | $19.92 M(-2.8%) |
| Oct 2011 | - | $20.48 M(-1.3%) |
| July 2011 | $20.76 M(+13.9%) | $20.76 M(+11.4%) |
| Apr 2011 | - | $18.63 M(-5.0%) |
| Jan 2011 | - | $19.61 M(+5.8%) |
| Oct 2010 | - | $18.52 M(+1.6%) |
| July 2010 | $18.23 M(+11.5%) | $18.23 M(+26.2%) |
| Apr 2010 | - | $14.45 M(-33.2%) |
| Jan 2010 | - | $21.62 M(+38.8%) |
| Oct 2009 | - | $15.58 M(-4.7%) |
| July 2009 | $16.35 M(+0.7%) | $16.35 M(-9.1%) |
| Apr 2009 | - | $17.99 M(+8.7%) |
| Jan 2009 | - | $16.55 M(+7.6%) |
| Oct 2008 | - | $15.38 M(-5.2%) |
| July 2008 | $16.23 M(-5.1%) | $16.23 M(+17.5%) |
| Apr 2008 | - | $13.82 M(+4.5%) |
| Jan 2008 | - | $13.23 M(-17.0%) |
| Oct 2007 | - | $15.94 M(-6.8%) |
| July 2007 | $17.11 M(+188.2%) | $17.11 M(+72.8%) |
| Apr 2007 | - | $9.90 M(+25.9%) |
| Jan 2007 | - | $7.86 M(-0.7%) |
| Oct 2006 | - | $7.92 M(+33.3%) |
| July 2006 | $5.94 M | $5.94 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2006 | - | $6.97 M(+31.0%) |
| Jan 2006 | - | $5.32 M(-13.8%) |
| Oct 2005 | - | $6.18 M(-24.7%) |
| July 2005 | $8.20 M(+32.9%) | $8.20 M(+36.1%) |
| Apr 2005 | - | $6.02 M(-14.7%) |
| Jan 2005 | - | $7.06 M(-39.5%) |
| Oct 2004 | - | $11.66 M(+89.1%) |
| July 2004 | $6.17 M(-5.1%) | $6.17 M(+18.2%) |
| Apr 2004 | - | $5.22 M(+0.2%) |
| Jan 2004 | - | $5.21 M(-16.7%) |
| Oct 2003 | - | $6.25 M(-3.8%) |
| July 2003 | $6.50 M(+42.5%) | $6.50 M(+17.3%) |
| Apr 2003 | - | $5.54 M(+1.7%) |
| Jan 2003 | - | $5.44 M(+9.3%) |
| Oct 2002 | - | $4.98 M(+9.3%) |
| July 2002 | $4.56 M(-15.8%) | $4.56 M(-28.6%) |
| Apr 2002 | - | $6.38 M(+3.8%) |
| Jan 2002 | - | $6.15 M(+24.7%) |
| Oct 2001 | - | $4.93 M(-9.0%) |
| July 2001 | $5.41 M(-5.2%) | $5.41 M(+31.5%) |
| Apr 2001 | - | $4.12 M(-4.0%) |
| Jan 2001 | - | $4.29 M(-1.9%) |
| Oct 2000 | - | $4.37 M(-23.5%) |
| July 2000 | $5.71 M(+73.0%) | $5.71 M(+95.6%) |
| Apr 2000 | - | $2.92 M(-5.8%) |
| Jan 2000 | - | $3.10 M(-11.4%) |
| Oct 1999 | - | $3.50 M(+6.1%) |
| July 1999 | $3.30 M(-2.9%) | $3.30 M(+22.2%) |
| Apr 1999 | - | $2.70 M(-10.0%) |
| Jan 1999 | - | $3.00 M(-6.3%) |
| Oct 1998 | - | $3.20 M(-5.9%) |
| July 1998 | $3.40 M(0.0%) | $3.40 M(+13.3%) |
| Apr 1998 | - | $3.00 M(-9.1%) |
| Jan 1998 | - | $3.30 M(+26.9%) |
| Oct 1997 | - | $2.60 M(-23.5%) |
| July 1997 | $3.40 M(-54.7%) | $3.40 M(+17.2%) |
| Apr 1997 | - | $2.90 M(+16.0%) |
| Jan 1997 | - | $2.50 M(-34.2%) |
| Oct 1996 | - | $3.80 M(-49.3%) |
| July 1996 | $7.50 M(-34.2%) | $7.50 M(-28.6%) |
| Apr 1996 | - | $10.50 M(-0.9%) |
| Jan 1996 | - | $10.60 M(+3.9%) |
| Oct 1995 | - | $10.20 M(-10.5%) |
| July 1995 | $11.40 M(-17.4%) | $11.40 M(-5.0%) |
| Apr 1995 | - | $12.00 M(-0.8%) |
| Jan 1995 | - | $12.10 M(-19.9%) |
| Oct 1994 | - | $15.10 M(+9.4%) |
| July 1994 | $13.80 M(-9.8%) | $13.80 M(+32.7%) |
| Apr 1994 | - | $10.40 M(+26.8%) |
| Jan 1994 | - | $8.20 M(-42.3%) |
| Oct 1993 | - | $14.20 M(-7.2%) |
| July 1993 | $15.30 M(-8.9%) | $15.30 M(-6.1%) |
| Apr 1993 | - | $16.30 M(-0.6%) |
| Jan 1993 | - | $16.40 M(-1.2%) |
| Oct 1992 | - | $16.60 M(-1.2%) |
| July 1992 | $16.80 M(-65.1%) | $16.80 M(+17.5%) |
| Apr 1992 | - | $14.30 M(+3.6%) |
| Jan 1992 | - | $13.80 M(-71.4%) |
| Oct 1991 | - | $48.30 M(+0.2%) |
| July 1991 | $48.20 M(-10.4%) | $48.20 M(-15.1%) |
| Apr 1991 | - | $56.80 M(+0.4%) |
| Jan 1991 | - | $56.60 M(+6.4%) |
| Oct 1990 | - | $53.20 M(-1.1%) |
| July 1990 | $53.80 M(-9.6%) | $53.80 M(-6.3%) |
| Apr 1990 | - | $57.40 M(-2.2%) |
| Jan 1990 | - | $58.70 M(+0.7%) |
| Oct 1989 | - | $58.30 M(-2.0%) |
| July 1989 | $59.50 M(+17.6%) | $59.50 M(+17.6%) |
| July 1988 | $50.60 M(-2.7%) | $50.60 M(-2.7%) |
| July 1987 | $52.00 M(+2.6%) | $52.00 M(+2.6%) |
| July 1986 | $50.70 M(+6237.5%) | $50.70 M(+6237.5%) |
| July 1985 | $800.00 K(-66.7%) | $800.00 K(-66.7%) |
| July 1984 | $2.40 M | $2.40 M |
FAQ
- What is Enzo Biochem annual total liabilities?
- What is the all time high annual total liabilities for Enzo Biochem?
- What is Enzo Biochem annual total liabilities year-on-year change?
- What is Enzo Biochem quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enzo Biochem?
- What is Enzo Biochem quarterly total liabilities year-on-year change?
What is Enzo Biochem annual total liabilities?
The current annual total liabilities of ENZ is $29.65 M
What is the all time high annual total liabilities for Enzo Biochem?
Enzo Biochem all-time high annual total liabilities is $59.50 M
What is Enzo Biochem annual total liabilities year-on-year change?
Over the past year, ENZ annual total liabilities has changed by -$13.77 M (-31.71%)
What is Enzo Biochem quarterly total liabilities?
The current quarterly total liabilities of ENZ is $29.65 M
What is the all time high quarterly total liabilities for Enzo Biochem?
Enzo Biochem all-time high quarterly total liabilities is $59.50 M
What is Enzo Biochem quarterly total liabilities year-on-year change?
Over the past year, ENZ quarterly total liabilities has changed by -$2.38 M (-7.43%)